Supplement: Ramping Up Tech transfer

1 The report, conceived by the venture capital working group of the region's CEO Council for Growth, compares the Greater Philadelphia area to peer regions with strong life science industries and suggests strategies for advancing the region's commercialization potential. With so many excellent universities and research institutes in the area, more innovations should be ending up in the hands of entrepreneurs who can develop them into products, the report finds. In response, business leader

Written bySusan Brown
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

With so many excellent universities and research institutes in the area, more innovations should be ending up in the hands of entrepreneurs who can develop them into products, the report finds. In response, business leaders are beginning to make plans to attract more venture capital and more entrepreneurs to the region. Many of the area's research institutions are finding more effective ways to connect inventors with biotech and pharmaceutical businesses.

Interest in promoting life sciences in the region came into focus when the Biotechnology Industry Organization (BIO) held its international meeting in Philadelphia in 2005, according to Russel Kauffman, president and CEO of the Wistar Institute and a member of the CEO Council for Growth. At that time the Milken Institute, an economic think tank, released a report that was commissioned in 2003 by several area organizations to assess Greater Philadelphia's position relative to other life science hotspots such as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies